N-terminal pro-brain natriuretic peptide used for the prediction of coronary artery stenosis
Background The level of the inactive N‐terminal fragment of pro‐brain (B‐type) natriuretic peptide (NT‐proBNP) is a prognostic marker in patients with acute and chronic coronary artery disease (CAD). It might also be valuable for non‐invasive diagnosis of coronary artery disease. Materials and meth...
Saved in:
Published in | European journal of clinical investigation Vol. 37; no. 1; pp. 18 - 25 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.01.2007
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background The level of the inactive N‐terminal fragment of pro‐brain (B‐type) natriuretic peptide (NT‐proBNP) is a prognostic marker in patients with acute and chronic coronary artery disease (CAD). It might also be valuable for non‐invasive diagnosis of coronary artery disease.
Materials and methods The NT‐proBNP was measured in 781 consecutive patients with normal left ventricular function referred for coronary angiography owing to symptoms or signs of CAD. The diagnostic value of NT‐proBNP was assessed for predicting CAD at angiography.
Results Elevated NT‐proBNP levels were associated with the extent of CAD and with the female sex (P < 0·001). The ability of NT‐proBNP to predict significant coronary disease at angiography was assessed separately for men using a cut‐off point of 85 pg mL−1, positive likelihood ratio 2·2 (95% CI, 1·7–3·0), negative likelihood ratio 0·53 (95% CI 0·45–0·63) and area under the receiver‐operating‐characteristic (ROC) curve 0·72: for women, it was assessed using a cut‐off point of 165 pg mL−1, positive likelihood ratio 2·4 (95% CI, 1·7–3·4), negative likelihood ratio 0·55 (95% CI, 0·44–0·70) and area under ROC curve 0·71. In multiple logistic‐regression analysis, NT‐proBNP added significant independent predictive power to other clinical variables in models predicting CAD (odds ratio 2·76, 95% CI, 1·76–4·32, P < 0·001).
Conclusions The NT‐proBNP is a marker of non‐obstructive CAD and of significant coronary stenosis. In conjunction with other clinical information, measurement of NT‐proBNP with the use of sex‐specific reference ranges may improve the non‐invasive prediction of CAD. |
---|---|
Bibliography: | ArticleID:ECI1731 istex:63F8EF0B0BB427986485CC3A294886F0EFEEC2C7 ark:/67375/WNG-W6N7V18C-C Cardiovascular Center, University Hospital Zurich, Zurich (T. Wolber, C. Binggeli, F. Duru), Division of Cardiology, University Hospital, Basel (M. Maeder), Division of Cardiology (H. Rickli, P. Ammann) and Institute for Clinical Chemistry and Haematology (W. Riesen), Kantonsspital St. Gallen, Switzerland. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0014-2972 1365-2362 |
DOI: | 10.1111/j.1365-2362.2007.01731.x |